JP2007513608A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007513608A5 JP2007513608A5 JP2006538786A JP2006538786A JP2007513608A5 JP 2007513608 A5 JP2007513608 A5 JP 2007513608A5 JP 2006538786 A JP2006538786 A JP 2006538786A JP 2006538786 A JP2006538786 A JP 2006538786A JP 2007513608 A5 JP2007513608 A5 JP 2007513608A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleic acid
- ghrelin
- biologically active
- acid according
- sample
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03025743 | 2003-11-10 | ||
| EP03025743.0 | 2003-11-10 | ||
| PCT/EP2004/012739 WO2005049828A1 (en) | 2003-11-10 | 2004-11-10 | Nucleic acids specifically binding bioactive ghrelin |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2007513608A JP2007513608A (ja) | 2007-05-31 |
| JP2007513608A5 true JP2007513608A5 (https=) | 2007-12-27 |
| JP4823067B2 JP4823067B2 (ja) | 2011-11-24 |
Family
ID=34610046
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006538786A Expired - Fee Related JP4823067B2 (ja) | 2003-11-10 | 2004-11-10 | 生物活性グレリンに特異的に結合する核酸 |
Country Status (19)
| Country | Link |
|---|---|
| US (2) | US20070031840A1 (https=) |
| EP (1) | EP1682662A1 (https=) |
| JP (1) | JP4823067B2 (https=) |
| KR (1) | KR20060125743A (https=) |
| CN (1) | CN1894407A (https=) |
| AP (1) | AP2006003618A0 (https=) |
| AU (1) | AU2004291656A1 (https=) |
| BR (1) | BRPI0415872A (https=) |
| CA (1) | CA2544805A1 (https=) |
| CR (1) | CR8388A (https=) |
| EA (1) | EA009376B1 (https=) |
| EC (1) | ECSP066559A (https=) |
| IL (1) | IL175443A0 (https=) |
| MA (1) | MA28153A1 (https=) |
| NO (1) | NO20062663L (https=) |
| OA (1) | OA13282A (https=) |
| TN (1) | TNSN06132A1 (https=) |
| WO (1) | WO2005049828A1 (https=) |
| ZA (1) | ZA200603435B (https=) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7750140B2 (en) * | 2002-08-01 | 2010-07-06 | Noxxon Pharma Ag | Ghrelin binding nucleic acids |
| EP2290071B1 (en) | 2004-05-28 | 2014-12-31 | Asuragen, Inc. | Methods and compositions involving microRNA |
| CA2857881A1 (en) | 2004-11-12 | 2006-12-28 | Asuragen, Inc. | Methods and compositions involving mirna and mirna inhibitor molecules |
| AR052741A1 (es) * | 2005-04-08 | 2007-03-28 | Noxxon Pharma Ag | Acidos nucleicos de union a ghrelin |
| WO2008036765A2 (en) * | 2006-09-19 | 2008-03-27 | Asuragen, Inc. | Micrornas differentially expressed in pancreatic diseases and uses thereof |
| JP2010510964A (ja) * | 2006-09-19 | 2010-04-08 | アシュラジェン インコーポレイテッド | 治療的介入の標的としての、ｍｉＲ−１５、ｍｉＲ−２６、ｍｉＲ−３１、ｍｉＲ−１４５、ｍｉＲ−１４７、ｍｉＲ−１８８、ｍｉＲ−２１５、ｍｉＲ−２１６、ｍｉＲ−３３１、ｍｍｕ−ｍｉＲ−２９２−３ｐによって調節される遺伝子および経路 |
| DK2104737T3 (da) * | 2006-12-08 | 2013-05-27 | Asuragen Inc | Funktioner og formål for let-7 mikro-RNAer |
| WO2008073915A2 (en) * | 2006-12-08 | 2008-06-19 | Asuragen, Inc. | Micrornas differentially expressed in leukemia and uses thereof |
| WO2008073920A2 (en) * | 2006-12-08 | 2008-06-19 | Asuragen, Inc. | Mir-21 regulated genes and pathways as targets for therapeutic intervention |
| CA2671270A1 (en) * | 2006-12-29 | 2008-07-17 | Asuragen, Inc. | Mir-16 regulated genes and pathways as targets for therapeutic intervention |
| US20090232893A1 (en) * | 2007-05-22 | 2009-09-17 | Bader Andreas G | miR-143 REGULATED GENES AND PATHWAYS AS TARGETS FOR THERAPEUTIC INTERVENTION |
| US20090131354A1 (en) * | 2007-05-22 | 2009-05-21 | Bader Andreas G | miR-126 REGULATED GENES AND PATHWAYS AS TARGETS FOR THERAPEUTIC INTERVENTION |
| JP2010529966A (ja) * | 2007-06-08 | 2010-09-02 | アシュラジェン インコーポレイテッド | 治療的介入の標的としてｍｉＲ−３４によって調節される遺伝子および経路 |
| US8361714B2 (en) | 2007-09-14 | 2013-01-29 | Asuragen, Inc. | Micrornas differentially expressed in cervical cancer and uses thereof |
| US20090186015A1 (en) * | 2007-10-18 | 2009-07-23 | Latham Gary J | Micrornas differentially expressed in lung diseases and uses thereof |
| US8071562B2 (en) * | 2007-12-01 | 2011-12-06 | Mirna Therapeutics, Inc. | MiR-124 regulated genes and pathways as targets for therapeutic intervention |
| WO2009086156A2 (en) * | 2007-12-21 | 2009-07-09 | Asuragen, Inc. | Mir-10 regulated genes and pathways as targets for therapeutic intervention |
| US20090263803A1 (en) * | 2008-02-08 | 2009-10-22 | Sylvie Beaudenon | Mirnas differentially expressed in lymph nodes from cancer patients |
| EP2268832A2 (en) * | 2008-03-06 | 2011-01-05 | Asuragen, INC. | Microrna markers for recurrence of colorectal cancer |
| EP2271757A2 (en) * | 2008-03-26 | 2011-01-12 | Asuragen, INC. | Compositions and methods related to mir-16 and therapy of prostate cancer |
| US8258111B2 (en) | 2008-05-08 | 2012-09-04 | The Johns Hopkins University | Compositions and methods related to miRNA modulation of neovascularization or angiogenesis |
| US20100179213A1 (en) * | 2008-11-11 | 2010-07-15 | Mirna Therapeutics, Inc. | Methods and Compositions Involving miRNAs In Cancer Stem Cells |
| EP2493910A1 (en) | 2009-10-30 | 2012-09-05 | Tranzyme Pharma, Inc. | Macrocyclic ghrelin receptor antagonists and inverse agonists and methods of using the same |
| AU2012206750A1 (en) * | 2011-01-10 | 2013-07-18 | Noxxon Pharma Ag | Nucleic acid molecule having binding affinity to a target molecule and a method for generating the same |
| WO2013040251A2 (en) | 2011-09-13 | 2013-03-21 | Asurgen, Inc. | Methods and compositions involving mir-135b for distinguishing pancreatic cancer from benign pancreatic disease |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5614395A (en) * | 1988-03-08 | 1997-03-25 | Ciba-Geigy Corporation | Chemically regulatable and anti-pathogenic DNA sequences and uses thereof |
| EP0786469B1 (en) * | 1990-06-11 | 2006-03-01 | Gilead Sciences, Inc. | Methods of use of nucleic acid ligands |
| JPH11505527A (ja) * | 1995-05-03 | 1999-05-21 | ホワイトヘッド インスティチュート フォー バイオメディカル リサーチ | 鏡像異性体リガンドの同定 |
| US5780221A (en) * | 1995-05-03 | 1998-07-14 | Whitehead Institute For Biomedical Research | Identification of enantiomeric ligands |
| US20030211967A1 (en) * | 2001-05-07 | 2003-11-13 | Bryant Henry Uhlman | Method for selectively inhibiting ghrelin action |
| AU2001259056A1 (en) * | 2000-05-17 | 2001-11-26 | Eli Lilly And Company | Method for selectively inhibiting ghrelin action |
| CA2411667A1 (en) * | 2000-05-30 | 2001-12-06 | Merck & Co. Inc. | Ghrelin analogs |
| US7750140B2 (en) * | 2002-08-01 | 2010-07-06 | Noxxon Pharma Ag | Ghrelin binding nucleic acids |
| AR052741A1 (es) * | 2005-04-08 | 2007-03-28 | Noxxon Pharma Ag | Acidos nucleicos de union a ghrelin |
-
2004
- 2004-11-10 OA OA1200600147A patent/OA13282A/en unknown
- 2004-11-10 EA EA200600735A patent/EA009376B1/ru not_active IP Right Cessation
- 2004-11-10 AP AP2006003618A patent/AP2006003618A0/xx unknown
- 2004-11-10 BR BRPI0415872-5A patent/BRPI0415872A/pt not_active IP Right Cessation
- 2004-11-10 WO PCT/EP2004/012739 patent/WO2005049828A1/en not_active Ceased
- 2004-11-10 KR KR1020067009024A patent/KR20060125743A/ko not_active Withdrawn
- 2004-11-10 CA CA002544805A patent/CA2544805A1/en not_active Abandoned
- 2004-11-10 US US10/578,938 patent/US20070031840A1/en not_active Abandoned
- 2004-11-10 CN CNA2004800377977A patent/CN1894407A/zh active Pending
- 2004-11-10 JP JP2006538786A patent/JP4823067B2/ja not_active Expired - Fee Related
- 2004-11-10 AU AU2004291656A patent/AU2004291656A1/en not_active Abandoned
- 2004-11-10 EP EP04797787A patent/EP1682662A1/en not_active Ceased
-
2006
- 2006-05-02 ZA ZA200603435A patent/ZA200603435B/en unknown
- 2006-05-04 IL IL175443A patent/IL175443A0/en unknown
- 2006-05-09 TN TNP2006000132A patent/TNSN06132A1/fr unknown
- 2006-05-10 EC EC2006006559A patent/ECSP066559A/es unknown
- 2006-05-10 MA MA29015A patent/MA28153A1/fr unknown
- 2006-05-10 CR CR8388A patent/CR8388A/es not_active Application Discontinuation
- 2006-06-09 NO NO20062663A patent/NO20062663L/no not_active Application Discontinuation
-
2010
- 2010-02-24 US US12/711,415 patent/US20100261291A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007513608A5 (https=) | ||
| Jain et al. | Potential biomarkers and their applications for rapid and reliable detection of malaria | |
| Yao et al. | Hybridization assay of hepatitis B virus by QCM peptide nucleic acid biosensor | |
| JP4441618B2 (ja) | インフルエンザウイルスの検出方法 | |
| TW200844238A (en) | HLA alleles associated with adverse drug reactions and methods for detecting such | |
| CA2455731A1 (en) | Methods for evaluating pathologic conditions using extracellular rna | |
| EP2497828A1 (en) | Use of aptamers in therapy and/or diagnosis of autoimmune diseases | |
| JP2008520242A5 (https=) | ||
| JP2008509672A5 (https=) | ||
| JP6997709B2 (ja) | 全身性炎症反応症候群（ｓｉｒｓ）患者における合併症リスクを評価する方法 | |
| Nourizad et al. | Recent trends in aptamer-based nanobiosensors for detection of vascular endothelial growth factors (VEGFs) biomarker: a review | |
| CN110004149A (zh) | 一种程序性死亡受体-配体1的核酸适体及其应用 | |
| WO2007062568A1 (en) | Compounds used as mammalian cell amp-activated protein kinase(ampk) activators and their preparation methods and usages | |
| CN112424609A (zh) | 卒中的血液生物标志物 | |
| CN104894243A (zh) | 用于肿瘤细胞检测的核酸适配体探针、装置及其应用 | |
| Wolf et al. | Major differences in gene expression in human coronary smooth muscle cells after nebivolol or metoprolol treatment | |
| US11634717B2 (en) | DNA aptamer specifically binding to TB7.7, and use thereof | |
| JP2023548156A (ja) | 肝疾患の評価のためのキット、試薬、及び方法 | |
| WO2017148432A1 (zh) | 用于预测慢性乙肝患者对IFNα治疗的应答的方法和试剂盒 | |
| KR20140054905A (ko) | 당화혈색소에 특이적 앱타머 및 이를 포함하는 당화혈색소 검출용 조성물 | |
| KR20120092938A (ko) | 알파태아단백질에 특이적으로 결합하는 ｄｎａ 앱타머 및 이의 용도 | |
| PP et al. | Revolutionary advances in hypertension detection: Gold nanoparticle-enhanced miRNA-based electrochemical biosensors and emerging nanotechnologies | |
| WO2006080262A1 (ja) | Ａｇｅ－２アプタマー | |
| AU2005282636B2 (en) | Methods for assessing atherosclerosis | |
| WO2018128286A1 (ko) | 핵산의 신속 검출법 및 이를 이용한 질병의 신속 진단 방법 |